Abundant evidence manifests that a variety of well-known DNA methylations can be used as a promising biomarker for the early diagnosis of lung cancer, such as p16 [8], RASSF1A [9], APC [10], MGMT [11], DAPK [12] and RARβ [13]. Here, DAPK1 is linked to lung cancer.